by Allogeneic stem cell transplantation involves replacing a patient’s damaged or diseased bone marrow with healthy bone marrow stem cells from a genetically similar but not identical donor. It is used to treat various types of cancers like leukemia, myeloma and lymphoma. This process allows patients to receive high doses of chemotherapy and radiation therapy that are myeloablative as the donor stem cells are used to rescue and replace the recipient’s bone marrow post-treatment. The global Allogeneic Stem Cell Transplantation Market plays a crucial role in treating hematological cancers and has seen increasing demand due to growing cancer prevalence worldwide.
The global Allogeneic Stem Cell Transplantation Market is estimated to be valued at US$ 3.9 Bn in 2023 and is expected to exhibit a CAGR of 6.5% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
One of the key trends propelling the growth of the Allogeneic Stem Cell Transplantation Market is rising demand for peripheral blood as a stem cell source. Peripheral blood is gaining popularity as a stem cell source compared to traditional bone marrow due to its ability to offer faster engraftment. It involves extracting blood from the donor’s body and filtering out the stem cells. This makes the process less invasive for donors compared to bone marrow extraction via hip bones. It also yields a higher number of stem cells which results in quicker recovery for recipients. Rising awareness about benefits such as faster recovery is contributing to the increasing preference for peripheral blood over traditional bone marrow, thereby fueling the market growth.
SWOT Analysis
Strength: Allogeneic stem cell transplantation is the most commonly used method for hematopoietic stem cell transplantation. It helps treat certain cancers like leukemia and lymphoma and some non-cancerous blood, immune system, and metabolic disorders.
Weakness: The risks with allogeneic stem cell transplantation include graft versus host disease (GVHD), infections, and transplant related mortality. Finding a matching donor can also be challenging.
Opportunity: Increasing incidence of cancer, blood disorders, and other indications requiring stem cell transplantation presents ample growth opportunities. Rapid advancements in transplant technologies and procedures are also expanding the eligible patient pool.
Threats: High costs associated with the extensive workup, collection, processing, and transplant procedures pose affordability challenges. Stringent regulatory approvals for new stem cell therapies also delay product launches.
Key Takeaways
The Global Allogeneic Stem Cell Transplantation Market Size is expected to witness high growth over the forecast period of 2023 to 2030. The global Allogeneic Stem Cell Transplantation Market is estimated to be valued at US$ 3.9 Bn in 2023 and is expected to exhibit a CAGR of 6.5% over the forecast period 2023 to 2030.
The North America region currently dominates the allogeneic stem cell transplantation market due to advanced healthcare facilities, availability of skilled professionals, and growing prevalence of target diseases. Developed countries in Europe also account for a sizable share due to widespread donor registries and insurance coverage for stem cell therapies. Asia Pacific is poised to emerge as the fastest growing regional market owing to rising healthcare investments, inexpensive treatment costs, and increasing medical tourism in countries like India, China and Singapore.
Key players operating in the allogeneic stem cell transplantation are Wacker Neuson SE, Sany Heavy Industry Co. Ltd, Volvo Construction Equipment, Wirtgen Group, Caterpillar Inc., Atlas Copco, Terex Corporation, Zoomlion Heavy Industries Science & Technology Co Ltd, Fayat Group, BOMAG GmbH, and XCMG Co. Ltd. Rapid expansion of transplant centers and rising collaborations between pharma firms and clinical research organizations are helping these players strengthen their market position. In addition, growing focus on developing off-the-shelf and readily available stem cell products also presents new opportunities.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
Money Singh is a seasoned content writer with over four years of experience in the market research sector. Her expertise spans various industries, including food and beverages, biotechnology, chemicals and materials, defense and aerospace, consumer goods, etc.
